Enzyme Immunoassay Validation for the Detection of Buprenorphine in Urine

By Cirimele V.   Kintz P.   Lohner S.   Ludes B.  

Journal of Analytical Toxicology, Vol. 27, Iss. 2, 2003-03 ,pp. : 103-105

Oxford University Press

Access to resources Recommend Favorite

Development and GC–MS Validation of a Highly Sensitive Recombinant G6PDH-Based Homogeneous Immunoassay for the Detection of Buprenorphine and Norbuprenorphine in Urine

By Wang Guohong  

Journal of Analytical Toxicology, Vol. 31, Iss. 7, 2007-09 ,pp. : 377-382

Oxford University Press

Access to resources Recommend Favorite

Oral Fluid is a Viable Alternative for Monitoring Drug Abuse: Detection of Drugs in Oral Fluid by Liquid Chromatography–Tandem Mass Spectrometry and Comparison to the Results from Urine Samples from Patients Treated with Methadone or Buprenorphine

By Vindenes V.  

Journal of Analytical Toxicology, Vol. 35, Iss. 1, 2011-01 ,pp. : 32-39

Oxford University Press

Access to resources Recommend Favorite

Urinary Buprenorphine Concentrations in Patients Treated with Suboxone ® as Determined by Liquid Chromatography-Mass Spectrometry and CEDIA Immunoassay

By Hull Mindy J.  

Journal of Analytical Toxicology, Vol. 32, Iss. 7, 2008-09 ,pp. : 516-521

Oxford University Press

Access to resources Recommend Favorite

Evaluation of Buprenorphine LUCIO Immunoassay versus GC-MS Using Urines from a Workplace Drug Testing Program

By Alves Marcela Nogueira Rabelo   Piccinotti Alberto   Tameni Silvia   Polettini Aldo  

Journal of Analytical Toxicology, Vol. 37, Iss. 3, 2013-04 ,pp. : 175-178

Oxford University Press

Access to resources Recommend Favorite